 | Up a level |
Vandenput, L; Johansson, H; McCloskey, E V; Liu, E; Åkesson, K E; Anderson, F A; Azagra, R; Bager, C L; Beaudart, C; Bischoff-Ferrari, H A; Biver, E; Bruyère, O; Cauley, J A; Center, J R; Chapurlat, R; Christiansen, C; Cooper, C; Crandall, C J; Cummings, S R; da Silva, J A P; ... (2022). Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan. Osteoporosis international, 33(10), pp. 2103-2136. Springer-Verlag 10.1007/s00198-022-06435-6
Lippuner, K; Grifone, S; Schwenkglenks, M; Schwab, P; Popp, A W; Senn, C; Perrelet, Romain (2012). Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008. Osteoporosis international, 23(3), pp. 829-39. London: Springer-Verlag 10.1007/s00198-011-1660-8
Lippuner, K; Johansson, H; Borgström, F; Kanis, J A; Rizzoli, R (2012). Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporosis international, 23(11), pp. 2579-89. London: Springer-Verlag 10.1007/s00198-011-1869-6
Lippuner, K; Popp, A W; Schwab, P; Gitlin, M; Schaufler, T; Senn, C; Perrelet, Romain (2011). Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis. Osteoporosis international, 22(9), pp. 2487-97. London: Springer-Verlag 10.1007/s00198-010-1487-8
Rizzoli, R; Kraenzlin, M; Krieg, M A; Mellinghoff, H U; Lamy, O; Lippuner, K (2011). Indications to teriparatide treatment in patients with osteoporosis. Swiss medical weekly, 141, w13297. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13297
Rizzoli, R; Lippuner, K; Kraenzlin, M; Birkhaeuser, M (2011). [Osteoporosis in Switzerland in 2011: change since 2008]. Revue médicale suisse, 7(299), pp. 1291-2. Genève: Médecine & Hygiène
Boonen, S; Adachi, J D; Man, Z; Cummings, S R; Lippuner, K; Törring, O; Gallagher, J C; Farrerons, J; Wang, A; Franchimont, N; San Martin, J; Grauer, A; McClung, M (2011). Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. Journal of clinical endocrinology and metabolism, 96(6), pp. 1727-36. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2010-2784
Hadji, P; Lippuner, K; Concin, H; Scharla, S; Birkhäuser, M; Fahrleitner-Pammer, A; Stute, P; Finkenstedt, G; Resch, H; Defèr, A; Minne, H-W; Ringe, J D; Dimai, H; Ziller, V (2011). Statement der trinationalen Expertenrunde Osteoporose. Die individualisierte Osteoporosebehandlung: Sequenztherapie und spezielle Patientengruppen. Journal für Mineralstoffwechsel : Zeitschrift für Knochen- und Gelenkserkrankunge, 18(1), pp. 48-55. Krause & Pachernegg
Hadji, P; Lippuner, K; Concin, H; Scharla, S; Birkhäuser, M; Fahrleitner-Pammer, A; Finkenstedt, G; Jakob, FJ; Schwarz, H; Stute, Petra; Ziller, V (2010). Selektive Östrogenrezeptormodulatoren (SERMs) und neue Optionen. Osteologie - interdisziplinäre Zeitschrift für Knochen und Gelenke, 2010(4), pp. 384-391. Stuttgart: Schattauer
Popp, A W; Senn, C; Franta, O; Krieg, M A; Perrelet, Romain; Lippuner, K (2009). Tibial or hip BMD predict clinical fracture risk equally well: results from a prospective study in 700 elderly Swiss women. Osteoporosis international, 20(8), pp. 1393-9. London: Springer-Verlag 10.1007/s00198-008-0808-7
Lippuner, K; Johansson, H; Kanis, J A; Rizzoli, R (2009). Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporosis international, 20(7), pp. 1131-40. London: Springer-Verlag 10.1007/s00198-008-0779-8
Lippuner, K (2009). [Epidemiology of osteoporotic fractures in Switzerland]. Revue médicale suisse, 5(207), pp. 1304-8. Genève: Médecine & Hygiène
Lippuner, K; Ferrari, S (2008). Osteoporosetherapie mit Teriparatid. Hausarztpraxis - Fortschritte der Medizin, 2008(14) Zürich: Prime Public Media AG
Lippuner, K; Ferrari, S (2008). Traitement de l'ostéoporose par le tériparatide. Gériatrie pratique, 2008(14) Basel: Medien & Medizin Verlag MMV AG
Lippuner, K (2008). Monoklonale Antikörper in der Osteoporose-Behandlung: schon bald in der Praxis? Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 8(12-13), pp. 229-232. Basel: EMH Editores Medicorum Helveticorum
Lippuner, K (2008). L'ostéoprose en Suisse en 2008: un appel à action. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 8(Suppl 45) Basel: EMH Editores Medicorum Helveticorum
Lippuner, K; Popp, AW; Szucs, T; Scfhwenkglenks, M (2008). Kosteneffektivität einer Osteoporose-Behandlung nach systematischem Bevölkerungsscreening in der Schweiz: Auswirkungen der Preisreduktion des Alendronat-Originalpräparates. PharmacoEconomics, 2008(6), pp. 19-28. Heidelberg: Springer
Lippuner, K; Dobnig, H (2008). RANKL-Inhibition: Neue Option in der Osteoporose. Leading opinions - Orthopädie, 2008(2), pp. 21-22. Wien: Universimed
Lippuner, K (2008). Kalzium und Vitamin D in der Behandlung der Osteoporose. Rheumalist, 2008 Neuhausen (CH): Rosenfluh Publikationen AG
Devogelaer, J P; Brown, J P; Burckhardt, P; Meunier, P J; Goemaere, S; Lippuner, K; Body, J J; Samsioe, G; Felsenberg, D; Fashola, T; Sanna, L; Ortmann, C E; Trechsel, U; Krasnow, J; Eriksen, E F; Garnero, P (2007). Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis. Osteoporosis international, 18(9), pp. 1211-8. London: Springer 10.1007/s00198-007-0367-3
Lippuner, K (2007). Osteoporose heute: Erfolg durch gezielte Abklärung und Therapie. Hausarztpraxis - Fortschritte der Medizin(8), pp. 9-30. Zürich: Prime Public Media AG
Lippuner, K (2007). Menopause und Osteoporose. Medizin für die Frau, 4(2007), pp. 19-23.
Lippuner, K (2007). Das RANK/RANK-Ligand/OPG-System: Neuer Angriffspunkt in der Behandlung von Osteoporose und anderen Knochenstoffwechselstörungen. Osteoporose & Rheuma aktuell, 7(1), pp. 28-36. Leichlingen: mdm-Verl. für Med. Publ.
Lippuner, K; Neuenschwander, B (2007). Kalzium und Vitamin D in der Behandlung der Osteoporose. In: Rheumalist 2007 (pp. 34-42). 8212 Neuhausen: Rosenfluh Publikationen AG
Lips, P; Hosking, D; Lippuner, K; Norquist, J M; Wehren, L; Maalouf, G; Ragi-Eis, S; Chandler, J (2006). The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. Journal of internal medicine, 260(3), pp. 245-54. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2796.2006.01685.x
Gasser, KM; Mueller, C; Zwahlen, M; Kaufmann, M; Fuchs, G; Perrelet, Romain; Abetel, G; Bürgi, U; Lippuner, K (2005). Osteoporosis case finding in the general practice: phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometry. Osteoporosis international, 16(11), pp. 1353-62. London: Springer-Verlag 10.1007/s00198-005-1846-z
del Pozo, E; Popp, A W E; MacKenzie, A; Perrelet, Romain; Lamberts, S W J; Lippuner, K (2005). Graded doses of recombinant interleukin-1beta induce generalized osteopenia in rats without altering skeletal growth and joint integrity. Hormone research, 64(2), pp. 88-95. Basel: Karger 10.1159/000088169
Clemetson, I A; Popp, A; Lippuner, K; Ballmer, F; Anderson, S E (2004). Postpartum osteoporosis associated with proximal tibial stress fracture. Skeletal radiology, 33(2), pp. 96-8. Berlin: Springer-Verlag 10.1007/s00256-003-0721-2
Steiner, R; Meyer, K; Lippuner, K; Schmid, J-P; Saner, H; Hoppeler, H (2004). Eccentric endurance training in subjects with coronary artery disease: a novel exercise paradigm in cardiac rehabilitation? European journal of applied physiology, 91(5-6), pp. 572-8. Heidelberg: Springer-Verlag 10.1007/s00421-003-1000-6
Cornuz, Jacques; Krieg, Marc-Antoine; Sandini, Lorenzo; Ruffieux, Christiane; Van Melle, Guy; Burckhardt, Peter; Büche, D; Dambacher, M; Hartl, F; Häuselmann, H; Lippuner, K; Neff, M; Pancaldi, P; Rizzoli, R; Tanzi, F; Theiler, R; Tyndall, A; Wimpfheimer, C; SEMOF, research group (2003). Factors associated with the use of hormone replacement therapy among older women. Age and ageing, 32(6), pp. 675-8. Oxford: Oxford University Press 10.1093/ageing/afg099b
Lippuner, K (2003). Medical treatment of vertebral osteoporosis. European spine journal, 12 Suppl 2(Suppl 2), S132-S141. Berlin: Springer-Verlag 10.1007/s00586-003-0608-x
Krieg, M A; Cornuz, J; Ruffieux, C; Sandini, L; Büche, D; Dambacher, M A; Hartl, F; Häuselmann, H J; Kraenzlin, M; Lippuner, K; Neff, M; Pancaldi, P; Rizzoli, R; Tanzi, F; Theiler, R; Tyndall, A; Wimpfheimer, K; Burckhardt, P (2003). Comparison of three bone ultrasounds for the discrimination of subjects with and without osteoporotic fractures among 7562 elderly women. Journal of bone and mineral research, 18(7), pp. 1261-6. Hoboken, N.J.: Wiley-Blackwell 10.1359/jbmr.2003.18.7.1261
Casez, J-P; Tschopp, P; Sandberg Tschopp, A; Lippuner, K; Zingg, E; Jaeger, P (2003). Effects of nasal calcitonin on bone mineral density following parathyroidectomy in patients with primary hyperparathyroidism. Hormone research, 59(6), pp. 263-9. Basel: Karger 10.1159/000070623
von der Heiden, R; Balestra, A P G; Bianchetti, M G; Casaulta Aebischer, C; Mullis, P E; Lippuner, K; Jaeger, P (2003). Which factors account for renal stone formation in cystic fibrosis? Clinical nephrology, 59(3), pp. 160-3. München-Deisenhofen: Dustri-Verlag
Krieg, M A; Cornuz, J; Hartl, F; Kraenzlin, M; Tyndall, A; Häuselmann, H J; Lippuner, K; Rizzoli, R; Büche, D; Theiler, R; Dambacher, M A; Neff, M; Pancaldi, P; Tanzi, F; Wimpfheimer, K; Burckhardt, P (2002). Quality controls for two heel bone ultrasounds used in the Swiss Evaluation of the Methods of Measurement of Osteoporotic Fracture Risk Study. Journal of clinical densitometry, 5(4), pp. 335-41. New York, N.Y.: Elsevier 10.1385/JCD:5:4:335
Hans, D; Rizzoli, R; Thiébaud, D; Lippuner, K; Allaoua, S; Genton, L; Luzuy, F; Krieg, M A; Jaeger, P; Slosman, D O (2001). Reference data in a Swiss population. Discordance in patient classification using T-scores among calcaneum, spine, and femur. Journal of clinical densitometry, 4(4), pp. 291-8. New York, N.Y.: Elsevier 10.1385/JCD:4:4:291
Casez, J -P.; Pfammatter, R; Nguyen, Q -V.; Lippuner, K; Jaeger, P (2001). Diagnostic approach to hypercalcemia: relevance of parathyroid hormone and parathyroid hormone-related protein measurements. European journal of internal medicine, 12(4), pp. 344-349. Roma: Pozzi
Heini, P F; Berlemann, U; Kaufmann, M; Lippuner, K; Fankhauser, C; van Landuyt, P (2001). Augmentation of mechanical properties in osteoporotic vertebral bones – a biomechanical investigation of vertebroplasty efficacy with different bone cements. European spine journal, 10(2), pp. 164-71. Berlin: Springer 10.1007/s005860000204
Lippuner, K; Fuchs, G; Ruetsche, A G; Perrelet, Romain; Casez, J P; Neto, I (2000). How well do radiographic absorptiometry and quantitative ultrasound predict osteoporosis at spine or hip? A cost-effectiveness analysis. Journal of clinical densitometry, 3(3), pp. 241-9. New York, N.Y.: Elsevier 10.1385/JCD:3:3:241
Morselli, B; Neuenschwander, B; Perrelet, Romain; Lippuner, K (2000). [Osteoporosis diet]. Therapeutische Umschau, 57(3), pp. 152-60. Bern: Huber
Ruetsche, A G; Lippuner, K; Jaeger, P; Casez, J P (2000). Differences between dual X-ray absorptiometry using pencil beam and fan beam modes and their determinants in vivo and in vitro. Journal of clinical densitometry, 3(2), pp. 157-66. New York, N.Y.: Elsevier 10.1385/JCD:3:2:157
Laederach-Hofmann, K; Graf, C; Horber, F; Lippuner, K; Lederer, S; Michel, R; Schneider, M (1999). Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. International journal of eating disorders, 26(3), pp. 231-44. New York, N.Y.: John Wiley & Sons Inc. 10.1002/(SICI)1098-108X(199911)26:3<231::AID-EAT1>3.0.CO;2-6
Lippuner, K; del Pozo, E; MacKenzie, A; Jaeger, P (1999). Long-term systemic administration of human recombinant interleukin-1beta induces a dose-dependent fall in circulating parathyroid hormone in rats. Hormone research, 51(2), pp. 74-7. Basel: Karger 10.1159/000023318
Lippuner, K; Jaeger, P (1998). [Differential osteoporosis diagnosis in the woman]. Therapeutische Umschau, 55(11), pp. 685-95. Bern: Huber
Lippuner, K; Casez, J P; Horber, F F; Jaeger, P (1998). Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients. Journal of clinical endocrinology and metabolism, 83(11), pp. 3795-802. Chevy Chase, Md.: Endocrine Society 10.1210/jc.83.11.3795
Hänggi, W; Lippuner, K; Jaeger, P; Birkhäuser, M H; Horber, F F (1998). Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women. Clinical endocrinology, 48(6), pp. 691-9. Oxford: Blackwell Scientific Publications 10.1046/j.1365-2265.1998.00481.x
Jost, B; Cripton, P A; Lund, T; Oxland, T R; Lippuner, K; Jaeger, P; Nolte, L P (1998). Compressive strength of interbody cages in the lumbar spine: the effect of cage shape, posterior instrumentation and bone density. European spine journal, 7(2), pp. 132-41. Berlin: Springer 10.1007/s005860050043
Lippuner, K; von Overbeck, J; Perrelet, Romain; Bosshard, H; Jaeger, P (1997). Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporosis international, 7(5), pp. 414-25. London: Springer 10.1007/PL00004149
Hänggi, W; Lippuner, K; Riesen, W; Jaeger, P; Birkhäuser, M H (1997). Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study. British journal of obstetrics and gynaecology, 104(6), pp. 708-17. Oxford: Blackwell Scientific Publications 10.1111/j.1471-0528.1997.tb11982.x
Mullis, P E; Yoshimura, N; Kuhlmann, B; Lippuner, K; Jaeger, P; Harada, H (1997). Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. Journal of clinical endocrinology and metabolism, 82(6), pp. 1739-45. Chevy Chase, Md.: Endocrine Society 10.1210/jc.82.6.1739
Lippuner, K; Haenggi, W; Birkhaeuser, M H; Casez, J P; Jaeger, P (1997). Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone. Journal of bone and mineral research, 12(5), pp. 806-12. Hoboken, N.J.: Wiley-Blackwell 10.1359/jbmr.1997.12.5.806
Bühler, D W; Berlemann, U; Lippuner, K; Jaeger, P; Nolte, L P (1997). Three-dimensional primary stability of cementless femoral stems. Clinical biomechanics, 12(2), pp. 75-86. Kidlington, UK: Elsevier 10.1016/S0268-0033(96)00059-9
Oxland, T R; Lund, T; Jost, B; Cripton, P; Lippuner, K; Jaeger, P; Nolte, L P (1996). The relative importance of vertebral bone density and disc degeneration in spinal flexibility and interbody implant performance. An in vitro study. Spine, 21(22), pp. 2558-69. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/00007632-199611150-00005
Lippuner, K; Zehnder, H J; Casez, J P; Takkinen, R; Jaeger, P (1996). PTH-related protein is released into the mother's bloodstream during location: evidence for beneficial effects on maternal calcium-phosphate metabolism. Journal of bone and mineral research, 11(10), pp. 1394-9. Hoboken, N.J.: Wiley-Blackwell
Horber, F F; Kohler, S A; Lippuner, K; Jaeger, P (1996). Effect of regular physical training on age-associated alteration of body composition in men. European journal of clinical investigation EJCI, 26(4), pp. 279-85. Oxford: Wiley-Blackwell 10.1046/j.1365-2362.1996.124281.x
Lippuner, K; Haller, B; Casez, J P; Montandon, A; Jaeger, P (1996). Effect of disodium monofluorophosphate, calcium and vitamin D supplementation on bone mineral density in patients chronically treated with glucocorticosteroids: a prospective, randomized, double-blind study. Mineral and electrolyte metabolism, 22(4), pp. 207-13. Basel: Karger
Tschopp, A B; Lippuner, K; Jaeger, P; Merz, V W; Danuser, H; Studer, U E (1996). No evidence of osteopenia 5 to 8 years after ileal orthotopic bladder substitution. Journal of urology, 155(1), pp. 71-5. New York, N.Y.: Elsevier
Steiger, U; Lippuner, K; Jensen, E X; Montandon, A; Jaeger, P; Horber, F F (1995). Body composition and fuel metabolism after kidney grafting. European journal of clinical investigation EJCI, 25(11), pp. 809-16. Oxford: Wiley-Blackwell 10.1111/j.1365-2362.1995.tb01689.x
del Pozo, E; Lippuner, K; Ruch, W; Casez, J P; Payne, T; MacKenzie, A; Jaeger, P (1995). Different effects of cyclosporin A on bone remodeling in young and adult rats. Bone, 16(4 Suppl), 271S-275S. New York, N.Y.: Elsevier 10.1016/S8756-3282(95)80097-2
Hess, B; Lippuner, K; Takkinen, R; Villiger, L; Ackermann, D; Jaeger, P (1995). Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls. Nephrology, dialysis, transplantation, 10(9), pp. 1614-1619. Oxford: Oxford University Press 10.1093/ndt/10.9.1614
Berlemann, U; Cripton, P; Nolte, L P; Lippuner, K; Schläpfer, F (1995). New means in spinal pedicle hook fixation. A biomechanical evaluation. European spine journal, 4(2), pp. 114-22. Berlin: Springer 10.1007/BF00278923
Lippuner, K; Jaeger, P (1994). [Sports in women: what relationship with bone mass?]. Revue médicale de la Suisse romande, 114(6), pp. 517-22. Lausanne: Impr. Réunis
Haenggi, W; Casez, J P; Birkhaeuser, M H; Lippuner, K; Jaeger, P (1994). Bone mineral density in young women with long-standing amenorrhea: limited effect of hormone replacement therapy with ethinylestradiol and desogestrel. Osteoporosis international, 4(2), pp. 99-103. London: Springer 10.1007/BF01623232
Casez, J P; Troendle, A; Lippuner, K; Jaeger, P (1994). Bone mineral density at distal tibia using dual-energy X-ray absorptiometry in normal women and in patients with vertebral osteoporosis or primary hyperparathyroidism. Journal of bone and mineral research, 9(12), pp. 1851-7. Hoboken, N.J.: Wiley-Blackwell
Jaeger, P; Lippuner, K; Casez, J P; Hess, B; Ackermann, D; Hug, C (1994). Low bone mass in idiopathic renal stone formers: magnitude and significance. Journal of bone and mineral research, 9(10), pp. 1525-32. Hoboken, N.J.: Wiley-Blackwell
Casez, J P; Muehlbauer, R C; Lippuner, K; Kelly, T; Fleisch, H; Jaeger, P (1994). Dual-energy X-ray absorptiometry for measuring total bone mineral content in the rat: study of accuracy and precision. Bone and mineral, 26(1), pp. 61-8. Amsterdam: Elsevier 10.1016/S0169-6009(08)80162-6
Siegrist, D; Hess, B; Montandon, M; Takkinen, R; Lippuner, K; Jaeger, P (1993). [Urinary specific gravity--comparative measurements using reagent strips and refractometer in 340 morning urine samples]. Praxis - schweizerische Rundschau für Medizin, 82(4), pp. 112-6. Bern: Huber
Lippuner, K; Vogel, R; Tepic, S; Rahn, B A; Cordey, J; Perren, S M (1992). Effect of animal species and age on plate-induced vascular damage in cortical bone. Archives of orthopaedic and trauma surgery, 111(2), pp. 78-84. Berlin: Springer 10.1007/BF00443472
Lippuner, K; Büchler, U; Ganz, R (1990). [Partial femur head necrosis in adults--results with intertrochanteric osteotomy and revascularization]. Orthopäde, 19(4), pp. 224-30. Heidelberg: Springer-Medizin-Verlag
Matter, P; Lippuner, K (1988). [Preclinical care of accident victims--is it optimal?]. Zeitschrift für Unfallchirurgie, Versicherungsmedizin und Berufskrankheiten, 81(4), pp. 221-9. Bern: Huber
